Thailand Medical Device Procurement: NHSO Universal Coverage, E-Bidding & Market Access Guide (2026)

Why Thailand's Medical Device Procurement System Matters

Thailand is the largest medical device exporter in ASEAN and a rapidly growing domestic market valued at approximately $2.23 billion in 2024, projected to reach $2.5 billion by 2028 (CAGR ~6.9%). The country is building on its "Medical Hub of Asia" strategy under the Thailand 4.0 initiative, attracting both medical tourism and advanced healthcare investment.

What makes Thailand particularly significant for medical device manufacturers is its Universal Coverage Scheme (UCS), commonly known as the "Gold Card" system. Together with the Social Security Scheme and the Civil Servant Medical Benefit Scheme, Thailand's three public healthcare programs cover approximately 99% of the population — over 70 million people. The UCS alone serves approximately 50 million people, making the NHSO the dominant medical device purchaser in the country. This near-universal coverage drives consistent, large-scale procurement of medical devices across 927 government hospitals and 9,765 primary care health units.

The procurement of medical devices for Thailand's public healthcare system is primarily managed by the National Health Security Office (NHSO), with electronic procurement conducted through the e-Market and e-Bidding platforms developed by the Ministry of Finance. Understanding this system is essential for any manufacturer seeking to access Thailand's public-sector medical device market.

Thailand's Healthcare System and Procurement Structure

Three Public Healthcare Schemes

Thailand's public healthcare is organized into three main schemes:

Scheme	Administrator	Population Covered	Budget Source
Universal Coverage Scheme (UCS) — "Gold Card"	NHSO	~50 million (majority of population)	General tax revenue
Social Security Scheme (SSS)	Social Security Office	~12 million formal sector workers	Payroll contributions
Civil Servant Medical Benefit Scheme (CSMBS)	Comptroller General's Department	~5 million government employees and dependents	Government budget

The NHSO-managed UCS is by far the largest purchaser of medical devices in the public sector. In 2026, the NHSO has already spent over THB 7 billion (~$200 million) on domestically produced medical products alone, with total medical device procurement significantly higher when including imported products.

Key Institutions in Medical Device Procurement

Institution	Role
NHSO (National Health Security Office)	Manages Universal Coverage Scheme; largest public health purchaser; sets benefits package and procurement policy
Thai FDA (under Ministry of Public Health)	Regulatory approval of medical devices; market authorization
Ministry of Finance	Manages e-GP (electronic government procurement) platform including e-Market and e-Bidding
Ministry of Public Health (MOPH)	Policy oversight; manages public hospitals; health infrastructure investment
TCELS (Thailand Center of Excellence for Life Sciences)	Supports medical innovation and domestic industry development
Thai Innovation Registry	Lists Thai-developed innovations eligible for preferential procurement

Thai FDA Regulatory Requirements

Device Classification

Thailand classifies medical devices into four classes under regulations harmonized with the ASEAN Medical Device Directive (AMDD):

Class	Risk Level	Registration Pathway
Class I	Low risk	Listing notification
Class II	Low-moderate risk	Registration with technical documentation
Class III	Moderate-high risk	Registration with clinical evidence
Class IV	High risk	Registration with comprehensive clinical data

Foreign Manufacturer Requirements

Foreign manufacturers must:

1. Appoint a Local Authorized Representative (LAR) — A Thailand-licensed entity that serves as the regulatory liaison with Thai FDA
2. Submit a CSDT dossier — Common Submission Dossier Template (ASEAN format) including:
   • Device description and intended use
   • Quality management system (ISO 13485) evidence
   • Clinical evaluation report
   • Risk management file (ISO 14971)
   • Labeling and IFU in Thai language
3. Obtain market authorization — Thai FDA issues an Import License valid for the product

Recent Regulatory Updates (2026)

• New labeling requirements effective June 20, 2026, replacing the 2020 regulation, with a 2-year transition period through June 2028
• Annual reporting deadline extended from March 31 to May 31 each year (effective March 2026)
• Quarterly sales reporting now required for mercury-containing, radiation-emitting, and listed emergency-use devices
• SaMD annual reporting required from 2027 for professional-use software medical devices

Government Procurement: The e-GP System

Electronic Government Procurement (e-GP)

Thailand has progressively digitalized its public procurement system. The Ministry of Finance operates the e-GP platform, which includes:

Platform	Purpose	Threshold
e-Market	Online marketplace for direct purchasing	Below THB 500,000 (~$14,000)
Price Checking	Compare prices from multiple suppliers	THB 500,000 – 2 million (~$14,000–$56,000)
e-Bidding	Competitive electronic bidding	Above THB 2 million (~$56,000)

How e-Market Works

e-Market functions as an online marketplace where:

• Buyers (government hospitals and health units) browse supplier catalogs, compare products, and place purchase orders
• Suppliers register, list products with pricing, respond to quotation requests, and fulfill orders
• The Office of Public Procurement Management sets rules and ensures compliance

Purchases below THB 500,000 can be completed through an "agreed price" mechanism on e-Market, enabling faster procurement for lower-value items.

How e-Bidding Works

For medical device purchases exceeding THB 2 million, the e-Bidding process applies:

1. Procurement planning — The purchasing hospital or NHSO creates a procurement project with specifications
2. Announcement — The procurement is published on the e-GP platform (www.goprocurement.go.th) with technical specifications, quantity, delivery requirements, and evaluation criteria. A minimum period of 21 days is required between announcement and bid deadline
3. Supplier registration — Suppliers must register on the e-GP system and meet qualification requirements
4. Bid submission — Qualified suppliers submit electronic bids including price, technical compliance, and supporting documentation. Foreign bidders may submit documents in English accompanied by Thai translations
5. Evaluation — Bids are evaluated based on price (primary criterion) and technical compliance. There is no discrimination between Thai and foreign bidders under Thai procurement law
6. Award — The contract is awarded to the lowest-priced technically compliant bid
7. Contract execution — Purchase orders issued through the e-GP system; delivery tracked electronically

NHSO Bulk Procurement

The NHSO also conducts centralized bulk procurement for high-volume, standardized medical products used across the Universal Coverage Scheme. Key features:

• 3–5 year contracts — Providing market certainty for manufacturers
• Volume commitments — The NHSO aggregates demand across hundreds of facilities
• Standardized specifications — Products must meet NHSO-defined quality standards
• THB 7+ billion annual spend on domestically produced medical products (2026)

The Thai Innovation List and Domestic Preferences

Innovation List Scheme

Thailand has established a Thai Innovation List Scheme designed to promote domestic medical technology development. Key requirements:

• At least 30% of procurement by government agencies (including NHSO) for eligible goods and services must go to items or companies listed in the Innovation Registry
• Products include dental implants, colostomy bags, prosthetic feet, titanium cranial mesh implants, and Thai-developed rapid tests (e.g., OV-ATK for liver fluke infections)
• The NHSO uses a special "Green Channel" pathway to fast-track research-backed Thai-developed products into the Universal Coverage benefits package

Implications for Foreign Manufacturers

The domestic preference policy creates both challenges and opportunities:

Aspect	Impact on Foreign Manufacturers
Competitive disadvantage for commodity products	Domestic suppliers may receive preference in procurement evaluation
Opportunity for technology partnerships	Partnering with Thai manufacturers can provide access to Innovation List benefits
Differentiation through innovation	Advanced imported technologies not available domestically remain in demand
Local manufacturing incentive	Establishing manufacturing in Thailand can qualify products as "domestic"

Pricing and Reimbursement

Public Sector Pricing

In the public healthcare system, medical device pricing is largely determined through the procurement process:

Procurement Type	Pricing Mechanism
e-Market (below THB 500,000)	Supplier-listed catalog prices; hospitals negotiate individually
Price checking (THB 500K–2M)	Multi-supplier price comparison; lowest compliant offer typically selected
e-Bidding (above THB 2M)	Competitive bidding; lowest-priced technically compliant bid wins
NHSO bulk procurement	Negotiated pricing based on volume commitments over 3–5 year contracts

Universal Coverage Scheme Benefits

The UCS covers a defined benefits package that includes medical devices used in covered procedures. Reimbursement to healthcare providers is through a capitation and case-based payment system:

Payment Type	Description
Capitation	Fixed per-person annual payment to provider networks for primary and outpatient care
Case-based	Fixed payment per episode of care for inpatient procedures (similar to DRG)
Fee-for-service	Used for specific high-cost items and specialized services

Medical devices used in covered procedures are included in the case-based payment — hospitals purchase devices and the cost is absorbed within the per-case reimbursement. This creates strong incentives for cost-effective purchasing, which drives the emphasis on competitive bidding and price comparison.

Private Sector Pricing

Thailand's private hospital sector (approximately 370 registered private hospitals) is not subject to government procurement regulations. Pricing is negotiated directly between manufacturers/distributors and individual hospitals. The private sector typically:

• Pays higher prices than public procurement
• Prioritizes technology and brand over price
• Serves medical tourism patients and upper-income Thai population

Market Access for Foreign Suppliers

Entry Strategy Options

Strategy	Description	Pros	Cons
Local Authorized Representative + distributor	LAR handles regulatory; distributor handles commercial sales and procurement	Fastest entry; lower investment	Less control; margin sharing
Thai subsidiary	Establish a local entity to hold licenses and manage sales directly	Full control; direct relationships	Higher investment; regulatory complexity
Foreign Business License (FBL)	Establish a wholly foreign-owned Thai company to import and sell directly	No dependency on third parties; full regulatory control; increasingly used by Chinese, European, and US manufacturers	Must comply with Thai Foreign Business Act; requires separate Thai FDA registration
Joint venture with Thai manufacturer	Partner with local manufacturer for production and distribution	Access to Innovation List benefits; domestic preference	Complex governance; technology transfer considerations
Direct e-GP participation	Register on e-GP and bid on procurement projects directly	Direct access to public procurement	Requires Thai entity; local presence needed

Registration on e-GP Platform

To participate in government medical device procurement, foreign suppliers must:

1. Register a Thai legal entity — Either directly or through a local partner
2. Obtain Thai FDA market authorization for all products offered
3. Register on the e-GP platform — Complete supplier registration including:
   • Company registration documents
   • Tax identification
   • Product catalog with Thai FDA license numbers
   • Pricing information
4. Maintain active product listings — Keep catalog, pricing, and compliance documentation current
5. Monitor procurement announcements — Track relevant e-Bidding opportunities

Market Opportunities by Segment

Segment	Opportunity Level	Notes
Advanced diagnostic imaging	High	High import reliance (two-thirds of devices imported); strong demand from both public and private sectors
Surgical equipment and implants	High	Growing domestic production but still heavily imported for advanced products
IVD and diagnostics	High	Growing demand; AI-enabled chest X-ray procurement by NHSO for 887 hospitals by FY2027
Digital health and AI	Very High	Government priority under Thailand 4.0; NHSO investing in AI-enabled diagnostics
Rehabilitation and elderly care devices	Growing	Thailand approaching "super-aged society" status by early 2030s
Consumables (gloves, syringes)	Low–Moderate	Dominated by strong domestic manufacturing sector; price-competitive
Aesthetic medicine devices	Growing	Private sector demand driven by medical tourism and wellness trends

Key Market Data

Metric	Value
Medical device market (2024)	~$2.23 billion
Projected market (2028)	~$2.5 billion
CAGR	~6.9%
Public healthcare facilities	927 government hospitals + 9,765 primary care units
Private hospitals	~370
Medical device distributors	~2,500
Import reliance	~67% of medical devices in use are imported
Top import sources	US, China, Germany, Japan
Export focus	Gloves (52%), optical lenses, syringes, catheters

Emerging Trends (2026)

NHSO AI and Digital Health Adoption

The NHSO has mandated the adoption of AI-enabled chest X-ray technology across public hospitals:

• FY2025: 167 public-sector hospitals
• FY2027: 887 hospitals total

This represents a significant milestone in the public healthcare system's adoption of innovative medical technology.

Centralized Procurement Reform

Inspired by Singapore's ALPS (Agency for Logistics and Procurement Services) model, there is growing advocacy for:

• Centralized procurement and logistics to cut inefficiency
• Improved transparency in procurement processes
• Faster adoption of Thai-made innovations into the benefits package

Green Channel Innovation Pathway

The NHSO's Green Channel allows research-backed Thai-developed medical innovations to enter the Universal Coverage benefits package more quickly, with streamlined evaluation and adoption processes.

Medical Tourism Growth

Thailand continues to position itself as a global medical tourism hub, driving private-sector demand for advanced medical devices. This creates a two-tier market:

• Public sector: Price-sensitive, volume-driven, e-GP procurement
• Private sector: Technology-driven, premium pricing, direct negotiation

Practical Checklist for Market Entry

Regulatory Pathway

• Appoint a Local Authorized Representative (LAR) in Thailand
• Prepare CSDT dossier in ASEAN format
• Obtain Thai FDA market authorization (Import License)
• Ensure labeling complies with 2026 labeling requirements (effective June 20, 2026)
• Establish annual and quarterly reporting systems

Public Procurement Pathway

• Register a Thai legal entity (or partner with one)
• Register on the e-GP platform
• List products with Thai FDA license numbers on e-Market
• Monitor e-Bidding announcements for relevant procurement projects
• Prepare competitive pricing (public procurement is price-driven)
• Consider Innovation List eligibility (if manufacturing in Thailand)

Commercial Strategy

• Evaluate public vs. private sector focus based on product type
• For public sector: develop cost-competitive offerings compliant with e-Bidding requirements
• For private sector: invest in KOL relationships and technology differentiation
• Consider technology partnerships with Thai manufacturers for Innovation List access
• Budget for local regulatory compliance and import licensing (6–12 months)
• Build Thai-language documentation, labeling, and marketing materials

Key Takeaways

1. The NHSO's Universal Coverage Scheme drives the largest public-sector procurement — Covering approximately 50 million people (~75% of the population) through 927+ government hospitals, the NHSO is Thailand's dominant medical device purchaser. Combined with the other two public schemes, Thailand achieves near-universal healthcare coverage for ~99% of its population.

2. e-Bidding is mandatory for purchases above THB 2 million — All public-sector medical device procurement above this threshold must go through competitive electronic bidding. Manufacturers must register on the e-GP platform to participate.

3. The Thai Innovation List creates a 30% domestic preference — Government agencies must procure at least 30% of eligible items from Innovation Registry companies. Foreign manufacturers should consider local partnerships or manufacturing to remain competitive.

4. Two-thirds of medical devices are imported — Thailand's domestic manufacturing is concentrated in low-to-mid-technology consumables (gloves, syringes, catheters). Advanced medical technology remains heavily import-dependent, creating clear opportunities for foreign manufacturers.

5. Regulatory compliance requires a local presence — A Local Authorized Representative is mandatory, and Thai FDA market authorization is required before any commercial sale. Plan 6–12 months for regulatory clearance and market entry.